Scientists crack mystery of how MS gene spread
The DNA of ancient cattle herders has revealed how diseases evolved in Europe over thousands of years.
The DNA of ancient cattle herders has revealed how diseases evolved in Europe over thousands of years.
The Food and Drug Administration has approved Narcan, a naloxone nasal spray that can reverse opioid overdoses and save lives, for over-the-counter use. In an announcement Wednesday, FDA Commissioner Robert M. Califf said the move is meant to address a “dire public health need” and will help increase access and reduce opioid overdose deaths in…
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device makers have seen the biggest rebound this month, and…
In today’s fast-paced corporate environment, achieving and maintaining a healthy work-life balance is more challenging than ever. The pressure to meet deadlines, achieve targets, and excel professionally often takes a toll on mental health. However, striking the right balance between work and personal life is crucial for overall well-being. Here are some strategies to help…
Some 35% of U.S. adults have gone online in an attempt to diagnose their health symptoms — and now Google is revealing which conditions they were most curious about this year. The search engine giant has released its annual “Year in Search,” which breaks down the top queries for everything from news and entertainment to…
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…